US Patent Issued to Bavarian Nordic on Sept. 29 for "Recombinant modified vaccinia virus (MVA) vaccine against coronavirus disease" (German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,282, issued on Sept. 29, was assigned to Bavarian Nordic A/S (Hellerup, Denmark).

"Recombinant modified vaccinia virus (MVA) vaccine against coronavirus disease" was invented by Jurgen Hausmann (Gundelfingen, Germany), Robin Steigerwald (Munich), Matthias Habjan (Puchheim, Germany), Jose Medina Echeverz (Munich) and Stephan Rambichler (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a recombinant Modified Vaccinia Virus Ankara (MVA) encoding a spike (S) protein or a part thereof, such as a receptor-binding domain (RBD), and additional antigenic sequences derived from other proteins of severe acute respiratory syndrome...